New hope for advanced prostate cancer: drug combo trial launches
NCT ID NCT06401980
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests whether adding darolutamide to standard treatments can help men with a certain type of advanced prostate cancer (mCRPC) live longer without their cancer getting worse. About 162 participants will receive either standard care alone or standard care plus darolutamide. The goal is to see if the combination improves outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire Vaudois CHUV
RECRUITINGLausanne, CH-1011, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpitaux Universitaires Genève HUG
RECRUITINGGeneva, 1211, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Inselspital
RECRUITINGBern, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Istituto Oncologico della Svizzera Italiana (IOSI)
RECRUITINGBellinzona, 6500, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kantonsspital Baden
RECRUITINGBaden, 5404, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kantonsspital Graubuenden
RECRUITINGChur, 7000, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kantonsspital St. Gallen
RECRUITINGSankt Gallen, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kantonsspital Winterthur
RECRUITINGWinterthur, 8401, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Luzerner Kantonsspital
RECRUITINGLucerne, 6004, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
OnkoZentrum Zürich - Standort Seefeld
TERMINATEDZurich, 8038, Switzerland
-
Stadtspital Triemli Zürich
RECRUITINGZurich, 8063, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tumorzentrum Aarau TZA
RECRUITINGAarau, 5000, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UniversitaetsSpital Zuerich
RECRUITINGZurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact